Clinical Trials Directory

Trials / Unknown

UnknownNCT02326727

Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Regional anesthesia may decrease the release of endogenous opioids, increase Natural Killer cell (NK) function and decrease development of metastasis. The recent analysis of the Cancer Registry has noted an improved 5-year survival in patients who received epidural analgesia during surgery for colorectal carcinoma.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineEpidural analgesia
DRUGFentanylGeneral Anesthesia
DRUGPropofolGeneral Anesthesia
DRUGIsofluraneGeneral Anesthesia
DRUGNitrous OxideGeneral Anesthesia

Timeline

Start date
2015-04-01
Primary completion
2017-04-01
Completion
2017-05-01
First posted
2014-12-29
Last updated
2014-12-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02326727. Inclusion in this directory is not an endorsement.

Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery (NCT02326727) · Clinical Trials Directory